DermRays Revolutionizing At-Home Laser Hair Removal with Innovative New Products

PLEASANTON, Calif., Nov. 11, 2024 /PRNewswire/ — As anticipation grows around DermRays’ latest developments, industry insiders are abuzz with speculation about the future direction of the company’s product line. Whether through a potential upgrade to the V8S Pro, a specially-designed device for men, or the integration of three wavelengths (755nm, 810nm, and 1064nm) into a single device, DermRays is poised to redefine the at-home laser hair removal market once again. Each innovation would represent a major advancement, bringing medical-grade laser technology directly into the hands of consumers.

With over 12 years in the industry, DermRays has, over the last two years, expanded into the home laser device market, driven by a dedication to providing salon-quality results at home. Their global reach spans from research and development in Germany to marketing operations in Hong Kong and manufacturing in China. This strategic footprint supports their commitment to leveraging advanced technology and expert knowledge for unparalleled results. Discover more about their story at https://www.dermrays.com/pages/about-us.

Committed to making premium laser devices accessible, DermRays celebrates every shopping season with exclusive discounts. This Veterans Day, November 11-15th, 2024, DermRays will offer $110 OFF sitewide, combining our signature quality with unmatched affordability to honor our customers’ needs.

DermRays remains dedicated to innovating for superior user experiences worldwide.

Media Contact:
Facebook: @dermraysofficial
Instagram: @dermrays_global
YouTube: @DermRays
TikTok: @dermrays.official

 

Subscribe on LinkedIn

Get the free newsletter

Subscribe to MedicaEx for top news, trends & analysis

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

PR Newswire is solely responsible for the content of the above news submissions. If there are any violations of laws, violations of the membership terms of this website, or the risk of infringing on the rights of third parties, PR Newswire will be solely responsible for legal and damage compensation. Responsibility has nothing to do with MedicaEx.

Are you in?

Subscribe to receive exclusive content and notifications to your inbox

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.